# reload+after+2024-01-22 09:28:11.828461
address1§251 Ballardvale Street
city§Wilmington
state§MA
zip§01887
country§United States
phone§781 222 6000
website§https://www.criver.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
fullTimeEmployees§20000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. James C. Foster J.D.', 'age': 72, 'title': 'Chairman, CEO & President', 'yearBorn': 1951, 'fiscalYear': 2022, 'totalPay': 2507989, 'exercisedValue': 6133567, 'unexercisedValue': 366263}, {'maxAge': 1, 'name': 'Ms. Flavia H. Pease', 'age': 50, 'title': 'Corporate Executive VP & CFO', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 772398, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Birgit  Girshick', 'age': 53, 'title': 'Corporate Executive VP & COO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 1151230, 'exercisedValue': 0, 'unexercisedValue': 688829}, {'maxAge': 1, 'name': 'Mr. Joseph W. LaPlume', 'age': 49, 'title': 'Corporate Executive Vice President of Corporate Development & Strategy', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 871346, 'exercisedValue': 887843, 'unexercisedValue': 573403}, {'maxAge': 1, 'name': 'Mr. William D. Barbo', 'age': 62, 'title': 'Chief Commercial Officer & Corporate Executive VP', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 928549, 'exercisedValue': 354379, 'unexercisedValue': 259644}, {'maxAge': 1, 'name': 'Mr. Michael Gunnar Knell', 'age': 46, 'title': 'Corporate Senior VP & Chief Accounting Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Julie  Frearson Ph.D.', 'title': 'Corporate Senior VP & Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark  Mintz', 'title': 'Corporate Senior VP & Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Todd  Spencer', 'title': 'Corporate Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matthew L. Daniel', 'title': 'Corporate Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§5
compensationRisk§7
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.374
priceToSalesTrailing12Months§2.7242532
currency§USD
dateShortInterest§1702598400
forwardEps§10.82
pegRatio§5.59
exchange§NYQ
quoteType§EQUITY
shortName§Charles River Laboratories Inte
longName§Charles River Laboratories International, Inc.
firstTradeDateEpochUtc§961767000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§3967529a-ede8-32eb-b408-a3032696a9fe
gmtOffSetMilliseconds§-18000000
targetHighPrice§270.0
targetLowPrice§189.0
targetMeanPrice§229.96
targetMedianPrice§220.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§13
quickRatio§0.962
earningsGrowth§-0.101
grossMargins§0.3689
ebitdaMargins§0.23066999
trailingPegRatio§1.8401
